未登录

H

Hirokazu Tanaka

Mie University

H指数:32

被引数:4,035

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MCL-1 as a tumor microenvironment-linked survival node in cholangiocarcinoma

MCL-1作为胆管癌中与肿瘤微环境相关的生存节点

Frontiers in Oncology

IF3.3

2026-09-090

OA

Potassium Ion Dynamics Imaging through Supported Lipid Bilayers with Surface Plasmon Resonance Microscopy

IF6.7

2022-10-104

PRE

Detection of Glutamate Encapsulated in Liposomes by Optical Trapping Raman Spectroscopy

IF4.3

2022-02-289

OAAI

Visualization of Accurate Guidewire Movement During Tip Detection in the New IVUS-Based 3D Wiring in CTO

Ct0中新的基于IVUS的3D布线中尖端检测期间精确导丝移动的可视化

JACC-CARDIOVASCULAR INTERVENTIONS

IF11.4

2020-04-013

OAAI

Does Surgeon Experience Affect Operative Time, Adverse Events and Continence Outcomes in Holmium Laser Enucleation of the Prostate? A Review of More Than 1,000 Cases

JOURNAL OF UROLOGY

IF6.8

2017-09-0139

PREAI

Dose effects of draining rectal gas in image-guided brachytherapy for gynecological cancer

RADIOTHERAPY AND ONCOLOGY

IF5.3

2017-05-011

OAAI

3-Tesla MRI Is More Useful for the Evaluation of Intraductal Spreading Area of Breast Cancer: A Comparative Study with Conventional 1.5-Tesla MRI

CANCER RESEARCH

IF16.6

2010-12-010

PRE

Anisotropic conductivity over in-plane and thickness directions in Nafion-117

JOURNAL OF THE ELECTROCHEMICAL SOCIETY

IF3.3

2006-01-0170

PREAI

Discovery of the first non-peptide full agonists for the human bradykinin B2 receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2004-04-16138

PREAI

A new class of nonpeptide bradykinin B2 receptor ligand, incorporating a 4-aminoquinoline framework.: Identification of a key pharmacophore to determine species difference and agonist/antagonist profile

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2004-04-0119

PREAI

A new series of highly potent non-peptide bradykinin B2 receptor antagonists incorporating the 4-heteroarylquinoline framework.: Improvement of aqueous solubility and new insights into species difference

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2004-03-0258

PREAI

Protein structure prediction in structure based drug design

基于结构的药物设计中的蛋白质结构预测

CURRENT MEDICINAL CHEMISTRY

IF3.5

2004-03-0153

PREAI

STRUCTURE OF FK506 - A NOVEL IMMUNOSUPPRESSANT ISOLATED FROM STREPTOMYCES

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2002-05-01629

PREAI

Orally active cephalosporins. Part 4: Synthesis, structure-activity relationships and oral absorption of novel 3-(4-pyrazolylmethylthio)cephalosporins with various C-7 side chains

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2002-05-0111

PREAI

STRUCTURE OF WS9326A, A NOVEL TACHYKININ ANTAGONIST FROM A STREPTOMYCES

JOURNAL OF ORGANIC CHEMISTRY

IF3.6

2002-05-0120

PREAI

Far-infrared spectra of amorphous titanium dioxide films

JOURNAL OF NON-CRYSTALLINE SOLIDS

IF3.5

2002-05-0113

PREAI

Synthesis and biological activity of 1-phenylsulfonyl-4-phenylsulfonylaminopyrrolidine derivatives as thromboxane A2 receptor antagonists

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2002-05-0128

PREAI

Orally active cephalosporins. Part 3: Synthesis, structure-activity relationships and oral absorption of novel C-3 heteroarylmethylthio cephalosporins

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2001-02-0117

PREAI

In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2000-01-01276

OAAI

Synthesis and biological activity of 4-methyl-3,5-dioxane derivatives as thromboxane A2 receptor antagonists

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

1999-11-0111

PREAI